Farnesoid X Receptor Agonists as Therapeutic Target for Cardiometabolic Diseases

Cardiometabolic diseases are characterized as a combination of multiple risk factors for cardiovascular disease (CVD) and metabolic diseases including diabetes mellitus and dyslipidemia. Cardiometabolic diseases are closely associated with cell glucose and lipid metabolism, inflammatory response and...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chao, Yang, Jie, Wang, Yu, Qi, Yingzi, Yang, Wenqing, Li, Yunlun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479173/
https://www.ncbi.nlm.nih.gov/pubmed/32982723
http://dx.doi.org/10.3389/fphar.2020.01247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479173/
https://www.ncbi.nlm.nih.gov/pubmed/32982723
http://dx.doi.org/10.3389/fphar.2020.01247

Ejemplares similares